Literature DB >> 1742204

Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide or quartz.

J M Davis1, A D Jones, B G Miller.   

Abstract

Rats were exposed for 1 year, with a 2-year follow-up, to dust clouds consisting of a mixture of amosite or chrysotile asbestos with either titanium dioxide or quartz. The addition of titanium dioxide to asbestos did not increase levels of pulmonary fibrosis above the amounts produced by chrysotile or amosite alone. Quartz, however, greatly increased fibrosis above that produced by the asbestos types alone. Both particulate dusts caused an increase in the numbers of pulmonary tumours and mesotheliomas compared to asbestos alone but while tumours in animals treated with asbestos and quartz tended to occur earlier than tumours with asbestos alone, in animals treated with dusts containing titanium dioxide, tumour production occurred later than with asbestos alone. In animals treated with mixtures of asbestos and quartz, there was evidence of increased transport of fibres across the visceral pleural surface and this may be associated with the finding of a higher proportion of pleural mesotheliomas than previously reported in experimental inhalation studies from any laboratory using the main asbestos varieties. The presence of particulate dusts made little difference to the amounts of amosite fibre retained in the lung tissue but, with chrysotile, titanium dioxide appeared to increase retention while quartz reduced it.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742204      PMCID: PMC2002319     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  18 in total

1.  Environmental mesothelioma in Turkey.

Authors:  Y I Bariş; M Artvinli; A A Sahin
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 2.  Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers?

Authors:  K Browne
Journal:  Br J Ind Med       Date:  1986-03

3.  Follow up study of workers manufacturing chrysotile asbestos cement products.

Authors:  M J Gardner; P D Winter; B Pannett; C A Powell
Journal:  Br J Ind Med       Date:  1986-11

4.  [Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their interpretation with regard to the carcinogenesis in humans (author's transl)].

Authors:  F Pott; K H Friedrichs; F Huth
Journal:  Zentralbl Bakteriol Orig B       Date:  1976-08

5.  Effects of electrostatic charge on the pathogenicity of chrysotile asbestos.

Authors:  J M Davis; R E Bolton; A N Douglas; A D Jones; T Smith
Journal:  Br J Ind Med       Date:  1988-05

6.  Experimental lesions in rats corresponding to advanced human asbestosis.

Authors:  J M Davis; R E Bolton; D Brown; H E Tully
Journal:  Exp Mol Pathol       Date:  1986-04       Impact factor: 3.362

7.  The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection.

Authors:  J M Davis; J Addison; R E Bolton; K Donaldson; A D Jones; T Smith
Journal:  Br J Exp Pathol       Date:  1986-06

8.  Erionite exposure and mesotheliomas in rats.

Authors:  J C Wagner; J W Skidmore; R J Hill; D M Griffiths
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

9.  Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats.

Authors:  J M Davis; S T Beckett; R E Bolton; P Collings; A P Middleton
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

10.  The effects of the inhalation of asbestos in rats.

Authors:  J C Wagner; G Berry; J W Skidmore; V Timbrell
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  10 in total

1.  Up-regulation of antigens on alveolar macrophages in quartz exposed rats.

Authors:  J Lundahl; A Eklund; M Hallgren; G Tornling
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

Review 2.  Health effects of refractory ceramic fibres: scientific issues and policy considerations.

Authors:  L R Glass; R C Brown; J A Hoskins
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

Review 3.  Non-neoplastic and neoplastic pleural endpoints following fiber exposure.

Authors:  V Courtney Broaddus; Jeffrey I Everitt; Brad Black; Agnes B Kane
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 4.  Morphological and chemical mechanisms of elongated mineral particle toxicities.

Authors:  Ann E Aust; Philip M Cook; Ronald F Dodson
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Spontaneous Primary Pleural Mesothelioma in Fischer 344 (F344) and Other Rat Strains: A Retrospective Review.

Authors:  Debra A Tokarz; Margarita M Gruebbel; Gabrielle A Willson; Jerry F Hardisty; Gail Pearse; Mark F Cesta
Journal:  Toxicol Pathol       Date:  2021-11-02       Impact factor: 1.902

Review 6.  Pulmonary carcinogenicity of inhaled particles and the maximum tolerated dose.

Authors:  G Oberdörster
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 7.  The role of clearance and dissolution in determining the durability or biopersistence of mineral fibers.

Authors:  J M Davis
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

8.  Introduction: INSERM-IARC-CNRS workshop on biopersistence of respirable synthetic fibers and minerals.

Authors:  J Bignon; R Saracci; J C Touray
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

9.  Rat pleural mesothelial cells show damage after exposure to external but not internal cigarette smoke.

Authors:  H S Sekhon; B Keeling; A Churg
Journal:  Environ Health Perspect       Date:  1993-09       Impact factor: 9.031

10.  Response of mouse lung to carbon deposition during injury and repair.

Authors:  I Y Adamson; H L Prieditis
Journal:  Environ Health Perspect       Date:  1995-01       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.